Related Experiment Videos
Prescribing of ACE inhibitors for cardiovascular disorders in general practice
J C Doyle1, D R Mottram, H Stubbs
1School of Pharmacy and Chemistry, Liverpool John Moores University, UK.
Insights
Prescribing patterns for angiotensin converting enzyme (ACE) inhibitors in cardiovascular care often deviate from established guidelines. This study highlights inconsistencies in ACE inhibitor use for heart failure and post-myocardial infarction patients, indicating a need for improved clinical practice.
Area of Science:
- Cardiology
- Pharmacology
- Primary Care Medicine
Background:
- Angiotensin converting enzyme (ACE) inhibitors are crucial in managing cardiovascular diseases.
- Current prescribing practices require evaluation against evidence-based guidelines.
Purpose of the Study:
- To analyze the prescribing patterns of ACE inhibitors in patients with heart failure and other cardiovascular conditions.
- To identify discrepancies between observed prescribing and recommended clinical guidelines.
Main Methods:
- Retrospective analysis of medical records from a large city-centre general practice.
- Inclusion criteria: patients receiving ACE inhibitors or diagnosed with heart failure.
- Data collected: concomitant conditions and drug treatments.
Main Results:
- ACE inhibitors were extensively prescribed for hypertension, sometimes without considering contraindications for other medications.
- Initiation of ACE inhibitors post-myocardial infarction frequently occurred outside recommended timeframes.
- Sixty percent of heart failure patients were not prescribed ACE inhibitors, even when no contraindications existed.
Conclusions:
- Prescribing patterns for ACE inhibitors do not consistently align with current medical literature and guidelines.
- Findings underscore the necessity for developing and implementing updated clinical guidelines for ACE inhibitor use.
- This research provides valuable data for improving cardiovascular pharmacotherapy in primary care settings.
Objective:
To investigate the prescribing patterns for angiotensin converting enzyme (ACE) inhibitors in the management of patients with heart failure and other cardiovascular disorders as part of a local project on heart failure using information collected from a Primary Care Information Initiative.
Method:
Patients from a large city-centre practice, who were receiving an ACE inhibitor or with a diagnosis of heart failure at the time of the study, were identified from medical records. Details of concomitant medical conditions and drug treatment were also recorded.
Results:
There was extensive prescribing of ACE inhibitors alone, in the treatment of patients with hypertension, where no contraindications for the use of thiazide diuretics or beta-blockers could be identified. ACE inhibitors were being prescribed for post-myocardial infarction patients, but the time for the initiation of treatment was rarely within that recommended in the literature. For those patients diagnosed with heart failure, 60% were not being treated with ACE inhibitors even where there were no contraindications.
Conclusion:
It is clear from the results of this study that overall prescribing patterns for ACE inhibitors are not always in accord with evidence from the literature. These findings provide valuable information for the initiation and development of clinical guidelines for prescribers.